Skip to main content
Curt Civin, MD, Oncology, Baltimore, MD

CurtCivinMD

Oncology Baltimore, MD

Professor, Pediatrics, University of Maryland School of Medicine

Are you Dr. Civin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 47 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    600 N Wolfe St
    Baltimore, MD 21287
    Phone+1 410-955-8751

Summary

  • Dr. Curt Civin, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is a Professor at University of Maryland School of Medicine.

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1974 - 1976
  • Harvard Medical School
    Harvard Medical SchoolClass of 1974

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1976 - 2022
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1992
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • Academic Labs Are Opening Back up. Still, Research Isn’t Exactly Back to Normal
    Academic Labs Are Opening Back up. Still, Research Isn’t Exactly Back to NormalJuly 20th, 2020
  • CITI Program, in Collaboration with Consortium, Launches Free Online Course “COVID-19: Back to Campus”
    CITI Program, in Collaboration with Consortium, Launches Free Online Course “COVID-19: Back to Campus”June 16th, 2020
  • New Anti-IL-7Rα Monoclonal Antibodies Show Efficacy Against T Cell Acute Lymphoblastic Leukemia in Pre-Clinical Models
    New Anti-IL-7Rα Monoclonal Antibodies Show Efficacy Against T Cell Acute Lymphoblastic Leukemia in Pre-Clinical ModelsAugust 22nd, 2019
  • Join now to see all